Soranib 200 mg Cipla
€54.00
Buying Soranib 200 mg Cipla is easy, trusted online store
Purchasing Soranib 200 mg Cipla can be done conveniently through various reputable online pharmacies. This medication, primarily used in oncology, is crucial for many patients seeking effective treatments. While obtaining Soranib online, it is essential to ensure that the pharmacy is licensed and offers genuine products. Users can benefit from competitive pricing and discreet packaging, making the process stress-free and trustworthy. Always consult with a healthcare provider before starting any new medication, including Soranib, to ensure it aligns with your health needs.
General information about Soranib 200 mg Cipla, formulation and presentation
Soranib, manufactured by Cipla, is an oral medication containing the active ingredient sorafenib. It is primarily indicated for the treatment of certain types of cancer, including renal cell carcinoma and hepatocellular carcinoma. Soranib is designed to inhibit tumor growth by targeting specific pathways involved in cancer cell proliferation and angiogenesis. The formulation of Soranib 200 mg Cipla typically comes in the form of oral tablets, enabling easy ingestion. Each tablet is carefully formulated to ensure consistent dosing and efficacy.
The presentation usually includes:
- 200 mg tablets, packaged in a blister strip.
- Each strip may contain multiple tablets for a continuous treatment regime.
- Important information leaflet detailing usage, side effects, and storage instructions.
Mechanism of action, effects on metabolism
The efficacy of Soranib 200 mg hinges on its mechanism of action, primarily through the inhibition of multiple tyrosine kinases involved in tumor growth and angiogenesis. By blocking these signaling pathways, Soranib disrupts the proliferation of cancer cells and limits their blood supply, ultimately inhibiting tumor progression.
Additionally, Soranib influences metabolic processes by affecting how the body uses glucose and fat, which may impact energy levels and overall stamina. For athletes or those engaged in strenuous physical activities, understanding this can be vital; Soranib’s influence on metabolic pathways can lead to changes in performance metrics, emphasizing the need for careful monitoring when combined with sports pharmacology.
Benefits, faster recovery, greater potency Soranib 200 mg Cipla
Using Soranib 200 mg Cipla offers benefits beyond mere cancer avoidance; many users express notable improvements in overall health metrics. The medication’s ability to inhibit tumor growth often translates to a faster recovery process for patients. Enhanced potency of Soranib facilitates better management of adverse symptoms associated with cancer therapies, allowing individuals to engage more actively in their recovery journey.
This effect can be particularly beneficial for athletes who are recovering from injuries or surgeries. Improved recovery times due to enhanced cellular processes contribute to a more effective rehabilitation strategy. Furthermore, Soranib’s impact on metabolism may provide an edge in sustaining energy levels during recovery and training periods. Thus, athletes may find it a helpful component in their regimen, provided it is used under strict medical supervision.
Contraindications and safety
While Soranib 200 mg Cipla is highly effective, specific contraindications must be observed. It is essential for individuals considering this treatment to discuss their complete medical history with a healthcare professional. Notably, the use of Soranib is contraindicated in patients with:
- Severe liver impairment or active liver disease.
- History of allergic reactions to sorafenib or any of its components.
- Pregnancy or breastfeeding, due to potential risks to the fetus or infant.
Safety measures include regular monitoring of liver function and blood tests to assess overall health while on Soranib. Patients are advised to report any unexpected symptoms, such as unusual bruising or bleeding, to their healthcare provider immediately. Additionally, it is paramount to adhere to the prescribed dosage and not to use Soranib without professional guidance to prevent adverse effects.
In conclusion, Soranib 200 mg Cipla stands as a notable option in the realm of cancer treatment and can also have implications for those engaged in sports and physical recovery. However, careful consideration of its use, along with informed oversight, remains crucial for optimal benefits and safety.
| Active substance | Sorafenib |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Yes, can cause liver injury |
| Lab Test | Liver function tests are recommended |
| Strength | 200mg |
| Also known as | BAY 43-9006 |
| Blood pressure | Can cause hypertension |
| Trade name | Nexavar |
| Storage conditions | Store at room temperature, protect from moisture |
| Chemical name | 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide |
| Formula | C21H16ClF3N4O3 |
| Substance class | Kinase inhibitor |
| Main action | Antineoplastic agent |
| Half-life | Approximately 25 to 48 hours |
| Dosage (medical) | Typically 400 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Inhibits tumor cell proliferation and angiogenesis |
| Side effects | Diarrhea, rash, fatigue, hypertension, hand-foot skin reactions |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 30 tabs/bottle |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |


Reviews
There are no reviews yet.